P23 Evolution of inpatients with new hyperglycemia (ambiglycemia)
Introduction: Hyperglycemia in the inpatients is associated to poor clinical outcome, although there is controversy about the magnitude of this effect on diabetic or not diabetic patients. Objectives: To differentiate two populations of inpatients with new hyperglycemia: (A)- previously unknown Dia...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Sello Editorial Lugones
2020-11-01
|
| Series: | Revista de la Sociedad Argentina de Diabetes |
| Subjects: | |
| Online Access: | https://revistasad.com/index.php/diabetes/article/view/407 |
| Summary: | Introduction: Hyperglycemia in the inpatients is associated to poor clinical outcome, although there is controversy about the magnitude of this effect on diabetic or not diabetic patients.
Objectives: To differentiate two populations of inpatients with new hyperglycemia: (A)- previously unknown Diabetes Mellitus or debut, and (B)-unexpected Hyperglycemia; and to explore the associations between metabolic variables at admission, and clinical outcomes. We propose the term ambiglycemia (AmbiG) for this ambiguous glycemia (severity vs stress), with the same value but different meaning.
Methods: Prospective cohort study with 2 years follow-up, watching the evolution of inpatients with new hyperglycemia (>140mg/dl confirmed), comparing two groups according to basal HbA1c at hospitalization (A) ≥6.5% or (B) <6.5%, and reclassifying through a new measurement of HbA1c at least 3 months after discharge. Statistics: SPSS v20. |
|---|---|
| ISSN: | 0325-5247 2346-9420 |